Hyperglycemia induces protein nonenzymeatic glycosylation in brain neurons of diabetic rats at early stage

Neural Regeneration Research

Volumn 2, Issue 1, 2007, Pages 42-45

  Hu, Jing Sheng ^a   Ma, Xue Yi ^a   Sheng, Shu Li ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic mellitus; Hyperglycemia; Immunohistochemistry

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTISERUM; BOVINE SERUM ALBUMIN; GLUCOSE; POLYCLONAL ANTIBODY; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ASCITES; BODY MASS; BRAIN NERVE CELL; BRAIN TISSUE; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN GLYCOSYLATION; RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; WISTAR RAT;

EID: 84859955036     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-5374(07)60009-7     Document Type: Article

References (19)

1. McCall AL. The impact of diabetes on the CNS. Diabetes 1992;41(5):557-70
2. Klein JP, Waxman SG. The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol 2003;2(9):548-54
3. Helkala EL, Niskanen L, Viinamaki H, et al. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 1995;18(5):681-5
4. Odawara M, Tada K, Yamashita K. Decreased cerebral blood perfusion in an NIDDM patient with an A-to-G mutation in the mitochondrial gene; a possible contribution to cognition deficits in diabetes. Diabetologia 1995;38(8):1004-5
5. Mooradian AD. Central nervous system complications of diabetes mellitus-a perspective from the blood-brain barrier. Brain Res Brain Res Rev 1997;23(3):210-8
6. Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992;267(8):5133-8
7. Wei Q, Wang JY, Meng XB, et al. A new method for an immunized mouse used for preparing considerable polyclonal antibodies. Beijing Shifan Daxue Xuebao: Ziran Kexue Ban 1992;28(1):392
8. Meng J, Sakata N, Takebayashi S, et al. Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 1996;45(8):1037-43
9. Vlassara H, Bucala R. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes 1996;45 Suppl 3:S65-6
10. Murata T, Nagai R, Ishibashi T, et al. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 1997;40(7):764-9
11. Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995;270(43):25752-61
12. Mori T, Takahashi K, Higashi T, et al. Localization of advanced glycation end products of Maillard reaction in bovine tissues and their endocytosis by macrophage scavenger receptors. Exp Mol Pathol 1995;63(2):135-52
13. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 1994;91(12):5710-4
14. Kashiwagi A, Asahina T, Nishio Y, et al. Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 1996;45 Suppl 3:S84-6
15. Li JJ, Voisin D, Quiquerez AL, et al. Differential expression of advanced glycosylation end-products in neurons of different species. Brain Res 1994;641(2):285-8
16. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318(20):1315-21
17. Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets 2005;6(4):453-74
18. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267(21):14998-5004
19. Schmidt AM, Mora R, Cao R, et al. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem 1994;269(13):9882-8